Clinical Trials on Secondary Hypersplenism

Total 1409 results

Repros Therapeutics Inc.

Completed

Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function

Secondary Hypogonadism

United States
Pathalys Pharma
Launch Therapeutics

Recruiting

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 (PATH-1)

Secondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)

United States, Bulgaria, Spain, Portugal, Poland, Serbia
The First Affiliated Hospital of Dalian Medical...

Recruiting

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Long-Term Effects Secondary to Cancer Therapy

China
Repros Therapeutics Inc.
Celerion

Completed

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Isabel Forner-Cordero, MD, PhD.

Completed

Physical Therapies in the Decongestive Treatment of Lymphedema

Secondary Lymphedema | Primary Lymphedema

Spain
Gulhane School of Medicine

Completed

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

Secondary Hypogonadism

Turkey
University Hospital, Basel, Switzerland

Completed

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Taste Disorder, Secondary, Sweet

Switzerland
Memorial Sloan Kettering Cancer Center
Pharmacyclics LLC.

Active, not recruiting

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

Primary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)

United States
University College, London
National Multiple Sclerosis Society

Completed

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

Secondary Progressive Multiple Sclerosis

United Kingdom
Covis Pharma S.à.r.l.

Completed

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Raynaud's Phenomenon Secondary to Connective Tissue Disease

United States
Amgen

Terminated

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Chronic Kidney Disease | Hyperparathyroidism, Secondary

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
University of Lincoln
Nottingham University Hospitals NHS Trust

Completed

Behavioural Activation for Low Mood in Multiple Sclerosis (BALMS)

Depression | Secondary-progressive Multiple Sclerosis

United Kingdom
Amgen

Completed

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Hyperparathyroidism, Secondary

United States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Lymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System Lymphoma

United States
Technische Universität Dresden
GWT-TUD GmbH

Completed

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study (SIGNS)

Primary Immunodeficiency (PID) | Secondary Immunodeficiency (SID) | Neurological Autoimmune Disease

Germany
Clalit Health Services

Completed

Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density

Vitamin D Deficiency | Secondary Hyperparathyroidism | Osteomalacia

Israel
National Taiwan University Hospital

Recruiting

Involved Versus Elective Target SSRS for Spinal Metastases

Secondary Malignant Neoplasm of Spine

Taiwan
Istituto Ortopedico Rizzoli

Completed

Lymphodreinage Integrated With Kinesio Tape in TKA Patients (LINFOTAPE)

Pain | Edema Secondary | Joint Dysfunction | TOTAL KNEE ARTHROPLASTY

Italy
University Hospital, Bordeaux

Completed

Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy (NIDABRECHE)

Primary or Secondary Infertility

France
Tiziana Life Sciences LTD

Recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Secondary Progressive Multiple Sclerosis

United States
Novartis Pharmaceuticals

Completed

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Secondary Progressive Multiple Sclerosis

China, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Novartis Pharmaceuticals

Completed

A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. (OLIMPIC)

Choroidal Neovascularization Secondary to Pathologic Myopia

Italy
Abbott

Completed

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Secondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5

United States
Ludwig-Maximilians - University of Munich
Charité Universitätsmedizin, Department of Hematology, Oncology and Tumor...

Not yet recruiting

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Metastatic Colorectal Cancer | Multidisciplinary Communication | RAS Mutation | Secondary Intervention
Novartis

Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)

Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
AbbVie (prior sponsor, Abbott)

Completed

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience (PROTECT)

Secondary Hyperparathyroidism | Chronic Kidney Failure

Greece
Iain Bressendorff

Not yet recruiting

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD (CaT50HD)

Secondary Hyperparathyroidism | End-stage Kidney Disease
Chunling Jiang

Not yet recruiting

Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure

Secondary Hyperparathyroidism | End Stage Renal Failure
National Cancer Institute (NCI)

Completed

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome

United States
Northwell Health
Children's Hospital of Philadelphia

Completed

Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients

Hypertension Secondary to Kidney Transplant

United States
University of Lisbon

Unknown

Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial

Long-term Effects Secondary to Cancer Therapy in Adults

Portugal
University Hospital, Basel, Switzerland

Completed

Electrical Intra-cutaneous Half-sine Stimulation for Optimized Preferential C-fiber Activation

Pain Perception | Secondary Hyperalgesia

Switzerland
Wake Forest University Health Sciences

Completed

Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure (TEAMS-BP)

Hypertension Secondary

United States
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...
Azienda Socio Sanitaria Territoriale Nord Milano

Active, not recruiting

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism. (PROUD)

Parkinson Disease | Nurse-Patient Relations | Atypical Parkinsonism | Nurse Physician Relations | Secondary Parkinsonism

Italy
Opexa Therapeutics, Inc.

Completed

Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)

Multiple Sclerosis | Autoimmune Diseases of the Nervous System | Disease Progression | Secondary Progressive Multiple Sclerosis | Brain Atrophy

United States, Canada
AbbVie (prior sponsor, Abbott)

Completed

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous (QUALITIZE)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Greece
Assiut University

Not yet recruiting

Subtalar Arthrodesis by Single Versus Double Screws

Subtalar Osteoarthritis Secondary to Inflammatory Arthritis
University of Lausanne Hospitals

Completed

Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections

Secondary or Tertiary Peritonitis

Switzerland
Baptist Health South Florida
BeiGene

Recruiting

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Primary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Secondary Central Nervous System Lymphoma

United States
Seoul National University Hospital

Recruiting

The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder

Korea, Republic of
Novartis Pharmaceuticals

Terminated

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) (Blossom)

Macular Edema Secondary to Branch Retinal Vein Occlusion

China, Taiwan, Hong Kong, Philippines, Vietnam, Indonesia
University of Virginia

Withdrawn

Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States
Institute of Psychiatry and Neurology, Warsaw
Poznan University of Medical Sciences; Nalecz Institute of Biocybernetics and... and other collaborators

Recruiting

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). (CLASP-MS)

Multiple Sclerosis | Multiple Sclerosis, Secondary Progressive

Poland
Deltanoid Pharmaceuticals

Completed

A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis (2MD-7H-2B)

Kidney Failure, Chronic | Hyperparathyroidism, Secondary

United States
Regeneron Pharmaceuticals
Bayer

Completed

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Macular Edema Secondary to Central Retinal Vein Occlusion

United States, Canada, Colombia, Israel, India
National Cancer Institute (NCI)

Active, not recruiting

Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia,...

United States

Clinical Trials on Secondary Hypersplenism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations